IMTX
NASDAQ · Biotechnology
Immatics Nv
$8.66
-0.54 (-5.87%)
Open$9.20
Previous Close$9.20
Day High$9.20
Day Low$8.58
52W High$12.41
52W Low$5.05
Volume—
Avg Volume523.1K
Market Cap1.29B
P/E Ratio—
EPS$-1.71
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+792.0% upside
Current
$8.66
$8.66
Target
$77.25
$77.25
$52.47
$77.25 avg
$103.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 58.95M | 90.18M | 330.72M |
| Net Income | -239,918,912 | -330,315,161 | -35,950,365 |
| Profit Margin | -407.0% | -386.7% | -10.9% |
| EBITDA | -211,094,573 | -306,776,570 | -62,958,224 |
| Free Cash Flow | — | — | -53,039,983 |
| Rev Growth | -34.6% | -34.6% | -2.7% |
| Debt/Equity | 0.03 | 0.03 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |